
Epizeal 133.5mg/58mg Tablet CR
Marketer
Amazeal Life Science Pvt Ltd
Salt Composition
Sodium Valproate (133.5mg) + Valproic Acid (58mg)
Overview Epizeal 133.5mg/58mg Tablet CR
Combiflam XR 133.5mg/58mg tablets offer a dual-action approach to managing epilepsy, a neurological condition characterized by recurring seizures. This medication regulates aberrant brain activity, promoting nerve relaxation and thereby preventing seizure episodes. Administer Combiflam XR with food; dosage will be determined and potentially adjusted by your physician until your condition stabilizes. Therapeutic effects may take several weeks to manifest; consistent use is crucial for optimal benefits. Discontinuation should only occur under medical supervision, as abrupt cessation can lead to increased seizure frequency or exacerbation of any underlying bipolar disorder. Common adverse reactions include nausea and tremors; less frequent but potential side effects comprise vomiting, headaches, hepatic impairment, and upper abdominal discomfort. Most side effects are transient, but persistent or bothersome effects warrant medical consultation. Prior to commencing treatment, disclose any existing kidney or liver dysfunction, meningitis, depression, or suicidal ideation to your doctor. A comprehensive list of all concurrent medications, including oral contraceptives, is necessary, as interactions are possible. While use during pregnancy or breastfeeding requires careful consideration and potential dosage adjustments under medical guidance, it remains a possibility if deemed essential. Refrain from operating vehicles or machinery if drowsiness or dizziness occurs. Regular blood tests may be required to monitor treatment response. Alcohol consumption should be avoided due to potential exacerbation of side effects. Weight gain is a possible consequence; a balanced diet, limited high-calorie snacks, and regular exercise are recommended. Report any unusual mood or behavioral changes, new or worsening depression, or the emergence of suicidal thoughts or actions to your doctor immediately.
Primary Ingredients of Epizeal 133.5mg/58mg Tablet CR
No text provided. Please provide the text you want me to rephrase.
Uses of Epizeal 133.5mg/58mg Tablet CR
Seizure disorder
Major Benefits of Epizeal 133.5mg/58mg Tablet CR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Epizeal 133.5mg/58mg Controlled-Release tablet should be administered with a meal.
Common Side effects of Epizeal 133.5mg/58mg Tablet CR:
- Nausea
- Tremors
How to use Epizeal 133.5mg/58mg Tablet CR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. The Epizeal 133.5mg/58mg Controlled-Release tablet should be administered with a meal.
How Epizeal 133.5mg/58mg Tablet CR works:
Epizeal CR tablets (133.5mg/58mg) contain valproic acid and sodium valproate, both anti-seizure medications.
SAFETY ADVICE
AlcoholUNSAFE
Combining Epizeal 133.5mg/58mg CR tablets with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Use of Epizeal 133.5mg/58mg CR tablets during pregnancy poses a confirmed risk to the fetus. Prescribing may occur exceptionally in life-threatening circumstances where potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Prolonged-release Epizeal 133.5mg/58mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal to negligible drug transfer into breast milk, posing no identified risk to the infant.
DrivingUNSAFE
Taking Epizeal 133.5mg/58mg CR tablets may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Epizeal 133.5mg/58mg CR tablets appear to pose minimal risk for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary, though further information is limited. Physician consultation is advised. Patients with pre-existing kidney conditions should discuss use with their doctor.
LiverCAUTION
Patients with liver impairment should exercise caution when using Epizeal 133.5mg/58mg CR tablets. A dose modification of Epizeal 133.5mg/58mg CR tablets may be necessary; physician consultation is advised. Epizeal 133.5mg/58mg CR tablets are contraindicated in individuals with severe or active liver disease.
What if you forget to take Epizeal 133.5mg/58mg Tablet CR :
Should you forget to take your Epizeal 133.5mg/58mg CR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Epizeal 133.5mg/58mg Tablet CR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Category | Nervous system medications. |
